Table of Contents
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
|
Copegus 200 mg film-coated tablet
Copegus 400 mg film-coated tablet
|
|
|
Each film-coated tablet contains 200 milligrams of ribavirin.
Each film-coated tablet contains 400 milligrams of ribavirin.
For a full list of excipients, see section 6.1.
|
|
|
Film-coated tablet
Copegus 200mg: Light pink, flat oval-shaped film-coated tablet (marked with RIB 200 on one side and ROCHE on the opposite side).
Copegus 400mg: Reddish brown, flat oval-shaped film-coated tablet (marked with RIB 400 on one side and ROCHE on the opposite side).
|